Suzanne Crowe bought $6,391 of RCEL
director at AVITA Medical, Inc.. 486 shares at an average of $13.15, traded Dec 9, 2024, filed Jan 29, 2025.
Score components
- +15RoleDirector
- 0Trade size$6k at market
- 0Relative to holdingsHoldings up 1.3%
- 0Price contextMid range
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-010560, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 9, 2024 | POpen-market purchase Common Stock | +486 | $13.15 | $6,391 | 36,912 | Jan 29, 2025 |
Related signals
Other insiders at AVITA Medical, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 55Moderate | AVITA Medical, Inc. | Robert McNamara director | $45k 10,000 shares | +13% | |
| 56Moderate | AVITA Medical, Inc. | David D O'Toole CFO | $9,040 2,000 shares | +7% | |
| 41Moderate | AVITA Medical, Inc. | Robert McNamara director | $50k 10,000 shares | +15% | |
| 41Moderate | AVITA Medical, Inc. | David D O'Toole CFO | $9,620 2,000 shares | +7% | |
| 61Notable | AVITA Medical, Inc. | Robert McNamara director | $91k 11,000 shares | +24% | |
| 39Weak | AVITA Medical, Inc. | David D O'Toole CFO | $9,900 1,000 shares | +4% | |
| 43Moderate | AVITA Medical, Inc. | Robert McNamara director | $101k 10,000 shares | +28% | |
| 39Weak | AVITA Medical, Inc. | David D O'Toole CFO | $10k 1,000 shares | +4% | |
| 30Weak | AVITA Medical, Inc. | David D O'Toole CFO | $12k 975 shares | +4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.